Blake E. Michener

Array ( [id] => 2928533 [patent_doc_number] => 05196193 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-23 [patent_title] => 'Antivenoms and methods for making antivenoms' [patent_app_type] => 1 [patent_app_number] => 7/429791 [patent_app_country] => US [patent_app_date] => 1989-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 34737 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/196/05196193.pdf [firstpage_image] =>[orig_patent_app_number] => 429791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2703594 [patent_doc_number] => 04981684 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-01-01 [patent_title] => 'Formation of adjuvant complexes' [patent_app_type] => 1 [patent_app_number] => 7/426050 [patent_app_country] => US [patent_app_date] => 1989-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4039 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/981/04981684.pdf [firstpage_image] =>[orig_patent_app_number] => 426050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2737757 [patent_doc_number] => 05077392 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-12-31 [patent_title] => 'Process for activation of recombinant protein produced by prokaryotes' [patent_app_type] => 1 [patent_app_number] => 7/422948 [patent_app_country] => US [patent_app_date] => 1989-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 6506 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/077/05077392.pdf [firstpage_image] =>[orig_patent_app_number] => 422948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2836657 [patent_doc_number] => 05171568 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-15 [patent_title] => 'Recombinant herpes simplex gb-gd vaccine' [patent_app_type] => 1 [patent_app_number] => 7/416425 [patent_app_country] => US [patent_app_date] => 1989-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 18 [patent_no_of_words] => 22245 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/171/05171568.pdf [firstpage_image] =>[orig_patent_app_number] => 416425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2981888 [patent_doc_number] => 05204445 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-20 [patent_title] => 'Peptides and antibodies that inhibit integrin-ligand binding' [patent_app_type] => 1 [patent_app_number] => 7/415025 [patent_app_country] => US [patent_app_date] => 1989-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14364 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/204/05204445.pdf [firstpage_image] =>[orig_patent_app_number] => 415025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2940157 [patent_doc_number] => 05191064 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-02 [patent_title] => 'Non-A, non-B hepatitis virus antigen peptide' [patent_app_type] => 1 [patent_app_number] => 7/401271 [patent_app_country] => US [patent_app_date] => 1989-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20839 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/191/05191064.pdf [firstpage_image] =>[orig_patent_app_number] => 401271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2801073 [patent_doc_number] => 05147638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-15 [patent_title] => 'Inhibition of tumor growth by blockade of the protein C system' [patent_app_type] => 1 [patent_app_number] => 7/389617 [patent_app_country] => US [patent_app_date] => 1989-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 9283 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/147/05147638.pdf [firstpage_image] =>[orig_patent_app_number] => 389617 [rel_patent_id] =>[rel_patent_doc_number] =>)